期刊文献+

GSK-3β抑制剂氯化锂对糖尿病肾病大鼠肾组织核因子κB受体活化因子与其配体表达的影响 被引量:5

Effect of GSK-3β inhibitor on the expression of RANK-RANKL in rats kidney tissue with diabetic nephropathy
原文传递
导出
摘要 目的 探讨GSK-3β抑制剂氯化锂及核因子κB受体活化因子(RANK)与核因子κB受体活化因子配体(RANKL)对糖尿病肾病(DN)大鼠肾组织病理改变的影响及意义.方法 将实验大鼠分成正常对照组(NC组)、DN模型组(DN组)和GSK-3β抑制剂氯化锂干预组( LiCl组),各16只.考马斯亮蓝法检测24 h尿蛋白;肾脏组织切片行HE染色,观察大鼠肾脏病理改变;即时荧光定量逆转录聚合酶链反应(RT-qPCR)及免疫组织化学法(IHC)检测各组肾组织GSK-3β、RANK、RANKL的mRNA及蛋白的表达.结果 与NC组(14. 72±3. 37)g/24 h相比,DN组24 h尿蛋白水平(154. 17± 20. 65)g/24 h升高;与DN组相比,LiCl组24 h尿蛋白水平(107. 22±31. 15)g/24 h下降(P<0. 05).与NC组[(2. 10±0. 60)、(1. 10±0. 20)、(1. 21±0. 20);(19. 52±3. 20)、(1. 80±1. 10)、(1. 81±0. 50)]相比,DN组大鼠肾组织病理改变加重,GSK-3β、RANK、RANKL的mRNA及蛋白表达[(9. 10±2. 15)、(8. 95±2. 40)、(9. 90±2. 60);(32. 70±7. 20)、(19. 20±4. 32)、(20. 92±5. 90)]升高;与DN组相比,LiCl组大鼠肾组织病理改变减轻,GSK-3β、RANK、RANKL的mRNA及蛋白表达[(2. 70±0. 80)、(2. 32± 0. 65)、(3. 58±1. 10);(22. 35±3. 25)、(4. 20±2. 42)、(5. 90±2. 36);均P<0. 05]下降.结论 RANK和RANKL在DN发生发展中有重要作用;LiCl可通过激活Wnt信号通路,抑制GSK-3β,下调RANK和RANKL的表达,可一定程度上改善DN中的肾脏损害. Objective To investigate the effect and significance of GSK-3β inhibitor (LiCl)and RANK-RANKL on the renal tissue of diabetic nephropathy(DN)rats.Methods SD rats were divided into normal control group (NC),DN model group (DN)and GSK-3β inhibitor intervention group (LiCl). Twenty-four hour urine protein of rats were determined by Coomassie brilliant blue.Kidney tissue sections were stained by HE.The expression of GSK-3β,RANK and RANKL protein were determined by immunohistochemistry staining.The mRNA of GSK-3β,RANK,RANKL was detected by RT-qPCR.Results Compared with NC group[(14.72±3.37)g ],the level of 24-hour urinary protein [(154.17±20.65)g ] increased significantly in DN group;compared with DN Group,the level of 24-hour urinary protein [(107.22±31.15)g]decreased in LiClgroup(P<0.05).Compared with NC group (2.10±0.60,1.10± 0.20,1.21±0.20;19.52±3.20,1.80±1.10,1.81±0.50),the pathological changes of renal tissues of DN group aggravated,the mRNA and expression of protein of GSK-3β,RANK and RANKL increased(9.10± 2.15,8.95±2.40,9.90±2.60;32.70±7.20,19.20±4.32,20.92±5.90);compared with DN group,the pathological changes of renal tissues of LiClgroup alleviated,mRNA and the expression of protein of factors above declined(2.70±0.80,2.32±0.65,3.58±1.10;22.35±3.25,4.20±2.42,5.90±2.36;P<0.05). Conclusion RANK and RANKL play an important role in the development of DN,LiClinfluence Wnt and NF-κB signal pathway down-regulating RANK and RANKL to suspend development of diabetic nephropathy.
作者 周谊霞 郭永洪 李龙 吕利撒 覃瑛 李晓杰 徐锟 于燕妮 Zhou Yixia;Guo Yonghong;Li Long;Lyu Lisa;Qin Ying;Li Xiaojie;Xu Kun;Yu Yanni(Department of Pathology,Affiliated Hospital,Guizhou Medical University,Guiyang 550004,China)
出处 《中华病理学杂志》 CAS CSCD 北大核心 2018年第12期945-950,共6页 Chinese Journal of Pathology
基金 国家自然科学基金(31360280) 人社部留学人员科技活动优秀项目[(2015)192-1].
关键词 糖尿病肾病 氯化锂 大鼠 Diabetic nephropathies Lithium chloride Rats
  • 相关文献

参考文献2

二级参考文献30

  • 1梁超,袁亮,吴永贵,董婧,任克军,张炜,方芳,郝丽,张伯科.FK506对糖尿病大鼠早期肾脏肥大的抑制作用及机制[J].中华肾脏病杂志,2007,23(4):230-234. 被引量:12
  • 2Navarro-GonzalezJ F, Mora-Femrindez C, Muros de Fuentes M, et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy[J] . Nat Rev Nephrol , 2011,7(6) :327- 40.
  • 3Schena F P, Gesualdo L. Pathogenetic mechanisms of diabetic ne?phropathyj L] .J Am Soc Nephrol, 2005 ,16( I): 30 -3.
  • 4Perkins N D. Integrating cell-signalling pathways with NF -kappaB and IKK function[J] . Nat Rev Mol Cell BioI, 2007,8 ( 1 ) :49 - 62.
  • 5Viatour P, Merville M P, Bours V, et al. Phosphorylation of NF?kappaB and IkappaB proteins: implications in cancer and inflam?mation[J] . Trends Biochem Sci, 2005,30(1) :43 -52.
  • 6Phillips AO, Steadman R. Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerslitial injury [ J ]. Histol Histopatho1,2002,17 ( 1 ) :247-252.
  • 7Gluhovschi GH, Gluhovschi C, Vlad A, et al. Diabetic nephropathy and multiorga protection. Part [ J ]. Rom J InternMed,2011,49(3):163-177.
  • 8Gluhovsehi GH, Gluhovsehi C, Vlad A, et al. Diabetic nephropathy and multiorgan protection Part [ J]. RomJ Intem Med,2011,49(4): 237-249.
  • 9Li L, Zhao YW, Zeng JS, et al. Rituximab regulates the expression of the Raf kinase inhibitor protein via NF-kappaB in renal tissue of rats with diabetic nephropathy[ J ]. Genet Mol Res, 2013,12(3) :2973-2981.
  • 10Berthier CC, Zhang H, Schin M, et al. Enhanced expression of Janus kinase-sigual transducer and activator of transcription pathway members in human diabetic nephropathy [ J ]. Diabetes, 2009,58(2) : 469-477.

共引文献15

同被引文献74

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部